277 related articles for article (PubMed ID: 31291354)
1. Characterization of the unique In Vitro effects of unsaturated fatty acids on the formation of amyloid β fibrils.
Eto M; Hashimoto T; Shimizu T; Iwatsubo T
PLoS One; 2019; 14(7):e0219465. PubMed ID: 31291354
[TBL] [Abstract][Full Text] [Related]
2. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model.
Lim GP; Calon F; Morihara T; Yang F; Teter B; Ubeda O; Salem N; Frautschy SA; Cole GM
J Neurosci; 2005 Mar; 25(12):3032-40. PubMed ID: 15788759
[TBL] [Abstract][Full Text] [Related]
3. DHA supplemented in peptamen diet offers no advantage in pathways to amyloidosis: is it time to evaluate composite lipid diet?
Amtul Z; Keet M; Wang L; Merrifield P; Westaway D; Rozmahel RF
PLoS One; 2011; 6(9):e24094. PubMed ID: 21931647
[TBL] [Abstract][Full Text] [Related]
4. Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization.
Teng E; Taylor K; Bilousova T; Weiland D; Pham T; Zuo X; Yang F; Chen PP; Glabe CG; Takacs A; Hoffman DR; Frautschy SA; Cole GM
Neurobiol Dis; 2015 Oct; 82():552-560. PubMed ID: 26369878
[TBL] [Abstract][Full Text] [Related]
5. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
[TBL] [Abstract][Full Text] [Related]
6. The impact of cholesterol, DHA, and sphingolipids on Alzheimer's disease.
Grimm MO; Zimmer VC; Lehmann J; Grimm HS; Hartmann T
Biomed Res Int; 2013; 2013():814390. PubMed ID: 24575399
[TBL] [Abstract][Full Text] [Related]
7. Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice.
Oksman M; Iivonen H; Hogyes E; Amtul Z; Penke B; Leenders I; Broersen L; Lütjohann D; Hartmann T; Tanila H
Neurobiol Dis; 2006 Sep; 23(3):563-72. PubMed ID: 16765602
[TBL] [Abstract][Full Text] [Related]
8. Cerebrovascular β-amyloid deposition and associated microhemorrhages in a Tg2576 Alzheimer mouse model are reduced with a DHA-enriched diet.
Hur J; Mateo V; Amalric N; Babiak M; Béréziat G; Kanony-Truc C; Clerc T; Blaise R; Limon I
FASEB J; 2018 Sep; 32(9):4972-4983. PubMed ID: 29620941
[TBL] [Abstract][Full Text] [Related]
9. Unique molecular signatures of Alzheimer's disease amyloid β peptide mutations and deletion during aggregate/oligomer/fibril formation.
Poduslo JF; Howell KG
J Neurosci Res; 2015 Mar; 93(3):410-23. PubMed ID: 25377128
[TBL] [Abstract][Full Text] [Related]
10. Reelin delays amyloid-beta fibril formation and rescues cognitive deficits in a model of Alzheimer's disease.
Pujadas L; Rossi D; Andrés R; Teixeira CM; Serra-Vidal B; Parcerisas A; Maldonado R; Giralt E; Carulla N; Soriano E
Nat Commun; 2014 Mar; 5():3443. PubMed ID: 24599114
[TBL] [Abstract][Full Text] [Related]
11. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats.
Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O
J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387
[TBL] [Abstract][Full Text] [Related]
12. Effect of Varying Concentrations of Docosahexaenoic Acid on Amyloid Beta (1⁻42) Aggregation: An Atomic Force Microscopy Study.
Lee BY; Attwood SJ; Turnbull S; Leonenko Z
Molecules; 2018 Nov; 23(12):. PubMed ID: 30486385
[TBL] [Abstract][Full Text] [Related]
13. The genetic landscape for amyloid beta fibril nucleation accurately discriminates familial Alzheimer's disease mutations.
Seuma M; Faure AJ; Badia M; Lehner B; Bolognesi B
Elife; 2021 Feb; 10():. PubMed ID: 33522485
[TBL] [Abstract][Full Text] [Related]
14. Hyperspectral imaging signatures detect amyloidopathy in Alzheimer's mouse retina well before onset of cognitive decline.
More SS; Vince R
ACS Chem Neurosci; 2015 Feb; 6(2):306-15. PubMed ID: 25354367
[TBL] [Abstract][Full Text] [Related]
15. Oligomeric amyloid-beta induces MAPK-mediated activation of brain cytosolic and calcium-independent phospholipase A
Palavicini JP; Wang C; Chen L; Hosang K; Wang J; Tomiyama T; Mori H; Han X
Acta Neuropathol Commun; 2017 Jul; 5(1):56. PubMed ID: 28750656
[TBL] [Abstract][Full Text] [Related]
16. Clusterin contributes to early stage of Alzheimer's disease pathogenesis.
Oh SB; Kim MS; Park S; Son H; Kim SY; Kim MS; Jo DG; Tak E; Lee JY
Brain Pathol; 2019 Mar; 29(2):217-231. PubMed ID: 30295351
[TBL] [Abstract][Full Text] [Related]
17. Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD).
Hooijmans CR; Rutters F; Dederen PJ; Gambarota G; Veltien A; van Groen T; Broersen LM; Lütjohann D; Heerschap A; Tanila H; Kiliaan AJ
Neurobiol Dis; 2007 Oct; 28(1):16-29. PubMed ID: 17720508
[TBL] [Abstract][Full Text] [Related]
18. Concomitant detection of beta-amyloid peptides with N-terminal truncation and different C-terminal endings in cortical plaques from cases with Alzheimer's disease, senile monkeys and triple transgenic mice.
Härtig W; Goldhammer S; Bauer U; Wegner F; Wirths O; Bayer TA; Grosche J
J Chem Neuroanat; 2010 Sep; 40(1):82-92. PubMed ID: 20347032
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of the effects of phosphatidylcholine rich in DHA and EPA on Alzheimer's disease and the possible mechanisms in CHO-APP/PS1 cells and SAMP8 mice.
Che H; Zhou M; Zhang T; Zhang L; Ding L; Yanagita T; Xu J; Xue C; Wang Y
Food Funct; 2018 Jan; 9(1):643-654. PubMed ID: 29292421
[TBL] [Abstract][Full Text] [Related]
20. Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease.
Calon F; Lim GP; Morihara T; Yang F; Ubeda O; Salem N; Frautschy SA; Cole GM
Eur J Neurosci; 2005 Aug; 22(3):617-26. PubMed ID: 16101743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
